Answers are grounded in this paper and cite their sources.
Background: There has been an increased access to anti-retrovirals in resourceconstrained settings. However, few studies have addressed the area of adverse drug reactions in these settings.Objective: To determine the prevalence of adverse drugs reactions in HIV-infected persons receiving anti-retrovirals.Design: A retrospective cohort study.Setting: Kenyatta National Hospital, Comprehensive Care Centre.Subjects: Adult patients receiving anti-retroviral drug during the four year period between January 2003 and December 2006.Main outcome measures: The primary outcome was a documented adverse drug reaction after exposure to antiretrovirals.Results: Systematic random sampling was used to pick 350 patients’ files. There were 219 recorded adverse drug reactions in 170 (48.6%) patients (some patients had more than one adverse drug reaction). Peripheral neuropathy was the most common adverse drug reaction with a prevalence of 28.9% followed by lipid abnormalities at 14.3%. Conclusion: This study indicates a high prevalence of adverse drug reactions among HIV/AIDS patients on anti-retroviral therapy at Kenyatta National Hospital, Comprehensive Care Centre.
No takes yet. Share an insight, caveat, or question.
Mwangangi et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: